Balance Labs, Inc.
BLNCdata completeness 88%11 fiscal years on fileData notes: no data for concept 'netInvestmentIncome'; no data for concept 'gainsOnRealEstateSales'; no data for concept 'realEstateImpairment'; no data for concept 'dividendsPaid'; no data for concept 'incomeTaxExpense'
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $624,5901 | $247,5002 | — | — | $6,0003 |
| Net income | −$796,6964 | −$768,3515 | −$381,5716 | −$528,2237 | −$31.8M7 |
| Operating cash flow | −$56,8968 | $7,7539 | −$122,50210 | −$157,11011 | −$257,02411 |
| Capital expenditure | $9,50012 | — | — | — | — |
| Free cash flow (derived) | −$66,3968 | — | — | — | — |
| Total debt | — | $480,15513 | $491,49613 | — | $25,00014 |
| Cash & equivalents | $227,55815 | $235,31116 | $112,80917 | $13,19918 | $358,97518 |
| Diluted shares | 21.7M | 21.7M | 21.7M | 21.7M | 25.7M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on −$1.31 of net worth that earned you −$12.35 last year, against $0.01 of debt.
Not enough data in the filings for a return-on-capital reading.
seeing a moat in the numbers →Share count is up 19% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has fallen 95% — deleveraging.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-12-31 · accession 0001493152-23-012585 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-014644 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2025-12-31 · accession 0001493152-26-016088 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2021-12-31 · accession 0001493152-23-012585 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-014644 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001641172-25-004842 (NetIncomeLoss)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-016088 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001493152-23-012585 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-014644 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001641172-25-004842 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-016088 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0001493152-23-012585 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-014644 (LongTermDebt)
- 10-K · period ending 2025-12-31 · accession 0001493152-26-016088 (LongTermDebt)
- 10-K · period ending 2021-12-31 · accession 0001493152-23-012585 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0001493152-24-014644 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001641172-25-004842 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001493152-26-016088 (CashAndCashEquivalentsAtCarryingValue)